Exercise and Ibuprofen May Ease Chemo Brain, Study Shows

Most cancer patients report cognitive deterioration, such as memory loss and difficulty concentrating, as they undergo cancer treatments like chemotherapy and radiation. This condition, widely known as “chemo brain,” can significantly impact quality of life. Recent research suggests that two accessible interventions—exercise and a common over-the-counter drug, ibuprofen—can alleviate these cognitive effects. The study, which adds to a growing body of evidence, offers hope to millions of cancer survivors struggling with mental fog.

As this research moves through clinical trials, companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are focusing on developing cancer treatments that minimize or avoid cognitive side effects altogether. CNS Pharmaceuticals is undertaking R&D programs aimed at creating therapies that are effective against brain tumors while preserving cognitive function. Their work highlights a broader shift in oncology toward not just survival, but quality of life during and after treatment.

BioMedWire, a specialized communications platform covering the Biotech and Life Sciences sectors, reported on these developments. The platform, part of the Dynamic Brand Portfolio @ IBN, delivers news to a wide audience of investors and healthcare professionals. For more details, readers can explore the full article on BioMedWire's website, which includes insights from the research and company updates. This news matters because it underscores the potential for simple, low-cost interventions to improve cancer care and highlights ongoing efforts to develop kinder treatments.